Implantable devices in the coronary artery from metal to genes
dc.contributor.author | Muller, David W. M. | en_US |
dc.contributor.author | Topol, Eric J. | en_US |
dc.date.accessioned | 2006-04-10T14:35:52Z | |
dc.date.available | 2006-04-10T14:35:52Z | |
dc.date.issued | 1991-09 | en_US |
dc.identifier.citation | Muller, David W. M., Topol, Eric J. (1991/09)."Implantable devices in the coronary artery from metal to genes." Trends in Cardiovascular Medicine 1(6): 225-232. <http://hdl.handle.net/2027.42/29147> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T1D-4BWVW3P-1/2/1e844effb03e47d5b73613b491161367 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29147 | |
dc.description.abstract | Preliminary data from nonrandomized clinical trials suggest that, in selected subgroups of patients, the implantation of endovascular stents may improve the initial results of coronary dilatation, may successfully treat arterial dissection and abrupt closure, and may reduce the incidence of recurrent stenosis. The widespread use of stents remains limited, however, by the need for intensive anticoagulation to prevent arterial thrombosis. The development of sustained-release drug delivery systems and gene-transfer technology may enable local delivery of antithrombotic and antiproliferative therapies that would greatly increase the safety and applicability of these devices. | en_US |
dc.format.extent | 1397966 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Implantable devices in the coronary artery from metal to genes | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationother | Department of Cardiology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA | en_US |
dc.identifier.pmid | 21239300 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29147/1/0000189.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/1050-1738(91)90026-B | en_US |
dc.identifier.source | Trends in Cardiovascular Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.